• Markel Group will use an adverse development cover reinsurance agreement with Enstar to support its strategic focus on growing core specialty insurance.
• The agreement covers $4.8 billion in reserves for underwriting years 2025 and prior across run-off global reinsurance and exited insurance lines.
• Markel will retain the first $2.6 billion of subject reserves and retrocede the next $2.3 billion to Enstar.
• Adverse loss development coverage totals $1.2 billion above subject reserves, with a $120 million risk premium payable to Enstar.
• Closing is expected by fourth-quarter 2026, subject to regulatory approval; the transaction’s net impact on quarterly underwriting results is expected to be immaterial.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Markel Group Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202610281646PR_NEWS_USPR_____PH83790) on October 28, 2026, and is solely responsible for the information contained therein.